| 000 | 01375 a2200409 4500 | ||
|---|---|---|---|
| 005 | 20250513085602.0 | ||
| 264 | 0 | _c19960417 | |
| 008 | 199604s 0 0 eng d | ||
| 022 | _a0149-2918 | ||
| 024 | 7 |
_a10.1016/0149-2918(95)80076-x _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aLaw, A V | |
| 245 | 0 | 0 |
_aCost-effectiveness analyses of the conversion of patients with non-insulin-dependent diabetes mellitus from glipizide to glyburide and of the accompanying pharmacy follow-up clinic. _h[electronic resource] |
| 260 |
_bClinical therapeutics _c |
||
| 300 |
_a977-87 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAged, 80 and over |
| 650 | 0 | 4 | _aCost-Benefit Analysis |
| 650 | 0 | 4 |
_aDiabetes Mellitus, Type 2 _xdrug therapy |
| 650 | 0 | 4 | _aDrug Costs |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aGlipizide _xeconomics |
| 650 | 0 | 4 |
_aGlyburide _xeconomics |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHypoglycemic Agents _xeconomics |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aRetrospective Studies |
| 700 | 1 | _aPathak, D S | |
| 700 | 1 | _aSegraves, A M | |
| 700 | 1 | _aWeinstein, C R | |
| 700 | 1 | _aArneson, W H | |
| 773 | 0 |
_tClinical therapeutics _gvol. 17 _gno. 5 _gp. 977-87 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/0149-2918(95)80076-x _zAvailable from publisher's website |
| 999 |
_c8594700 _d8594700 |
||